Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
OBJECTIVES: To evaluate the predictive value of serum beta2-microglobulin (β2m) levels for virological breakthrough in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy.
Saved in:
Main Authors: | Ioannis S Elefsiniotis, Nikolaos Scarmeas, Irene Glynou, Konstantinos D Pantazis, Helen Kada, Christos Mavrogiannis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2004/864292 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Data concerning the Epidemiology of Hepatitis B Virus Infection in Greece
by: Konstantinos D. Pantazis, et al.
Published: (2008-01-01) -
Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
by: Ioannis S. Elefsiniotis, et al.
Published: (2009-01-01) -
Understanding virologic heterogeneity in chronic hepatitis B treatment
by: Renqi Luo, et al.
Published: (2025-02-01) -
Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”
by: Philippa C. Matthews, et al.
Published: (2025-02-01) -
Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy
by: Catherine Orrell, et al.
Published: (2011-01-01)